Search Within

Andrew D Seidman

Formats
  1. Journal Article (175)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
  4. Correspondence (3)
  5. Review (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Editorial (1)
Groups
  1. Breast Medicine Service (318)
  2. Department of Medicine (318)
  3. Solid Tumor Oncology Division (318)
  4. Survivorship Research (158)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (116)
  6. Epidemiology and Biostatistics (84)

More Groups

People
  1. Clifford Hudis (116)
  2. Larry Norton (99)
  3. Teresa Gilewski (38)
  4. Monica Fornier (37)
  5. Gabriella D'Andrea-Carlino (36)
  6. Violante Currie (32)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (9)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Breast Cancer Research and Treatment (25)
  3. Cancer Research (23)
  4. Clinical Breast Cancer (19)
  5. Seminars in Oncology (16)
  6. Oncology (Norwalk) (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. Elsevier Inc. (55)
  3. Springer (40)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (29)
  6. C M P Medica LLC * The Oncology Group (14)

More Publishers

Results (318)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic implications of receptor status and extracranial disease in patients with breast cancer brain metastases treated with stereotactic radiosurgery
    Meeting Abstract

    Yang, T.; Oh, J.; Folkert, M.; Morikawa, A.; Seidman, A. D.; Yamada, Y.; Chan, T. A.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • The search for an elusive uniform strategy for a heterogeneous disease: lesson learned?
    Journal Article

    Seidman, A. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer
    Journal Article

    Chen, X.; Stubblefield, M. D.; Custodio, C. M.; Hudis, C. A.; Seidman, A. D.; De Angelis, L. M.
    Journal of Clinical Neurophysiology (2013)

    Fulltext@MSK | Save
  • Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
    Journal Article

    Ang, C.; Jhaveri, K.; Patel, D.; Gewirtz, A.; Seidman, A.; Kemeny, N.
    Breast Journal (2013)

    Fulltext@MSK | Save
  • A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Tesetaxel: Activity of an oral taxane as first-line treatment in metastatic breast cancer
    Meeting Abstract

    Seidman, A. D.; Schwartzberg, L. S.; O'Shaughnessy, J.; D'Andrea, G.; Rubin, P.; Katz, S.; Danesi, H.; Itri, L.; Hudis, C.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: Preliminary results from a phase 2, single-arm feasibility study
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Fornier, M.; Lake, D.; Lehman, R.; Berkowitz, A. P.; Rege, J.; Liao, J.; Cox, D.; Seidman, A. D.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase I/II study of a novel dose-dense schedule of oral indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Seidman, A.; Gajria, D.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save